Allogene Therapeutics Inc (ALLO)
2.94
-0.06
(-2.00%)
USD |
NASDAQ |
Nov 05, 09:34
Allogene Therapeutics Enterprise Value: 182.71M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 182.71M |
| November 01, 2024 | 124.16M |
| October 31, 2024 | 89.65M |
| October 30, 2024 | 107.43M |
| October 29, 2024 | 140.88M |
| October 28, 2024 | 115.79M |
| October 25, 2024 | 65.60M |
| October 24, 2024 | 86.52M |
| October 23, 2024 | 134.61M |
| October 22, 2024 | 140.88M |
| October 21, 2024 | 140.88M |
| October 18, 2024 | 149.25M |
| October 17, 2024 | 117.88M |
| October 16, 2024 | 151.34M |
| October 15, 2024 | 122.06M |
| October 14, 2024 | 105.34M |
| October 11, 2024 | 109.52M |
| October 10, 2024 | 103.24M |
| October 09, 2024 | 107.43M |
| October 08, 2024 | 128.34M |
| October 07, 2024 | 94.88M |
| October 04, 2024 | 119.97M |
| October 03, 2024 | 101.15M |
| October 02, 2024 | 84.42M |
| October 01, 2024 | 113.70M |
| Date | Value |
|---|---|
| September 30, 2024 | 140.88M |
| September 27, 2024 | 163.89M |
| September 26, 2024 | 124.16M |
| September 25, 2024 | 103.24M |
| September 24, 2024 | 113.70M |
| September 23, 2024 | 113.70M |
| September 20, 2024 | 140.88M |
| September 19, 2024 | 163.89M |
| September 18, 2024 | 157.61M |
| September 17, 2024 | 157.61M |
| September 16, 2024 | 132.52M |
| September 13, 2024 | 174.34M |
| September 12, 2024 | 111.61M |
| September 11, 2024 | 163.89M |
| September 10, 2024 | 147.16M |
| September 09, 2024 | 73.97M |
| September 06, 2024 | 59.33M |
| September 05, 2024 | 80.24M |
| September 04, 2024 | 94.88M |
| September 03, 2024 | 80.24M |
| August 30, 2024 | 105.34M |
| August 29, 2024 | 111.61M |
| August 28, 2024 | 92.79M |
| August 27, 2024 | 115.79M |
| August 26, 2024 | 140.88M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-81.83M
Minimum
Nov 29 2023
6.280B
Maximum
May 22 2020
1.710B
Average
1.126B
Median
Enterprise Value Benchmarks
| ICU Medical Inc | 5.504B |
| OPKO Health Inc | 1.185B |
| Envista Holdings Corp | 4.092B |
| Outset Medical Inc | 34.82M |
| AIM ImmunoTech Inc | 8.843M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -66.36M |
| Total Expenses (Quarterly) | 66.44M |
| EPS Diluted (Quarterly) | -0.35 |
| Earnings Yield | -55.78% |
| Normalized Earnings Yield | -62.24 |